Strensiq and Urinary tract infection - a phase IV clinical study of FDA data

Summary:

Urinary tract infection is reported as a side effect among people who take Strensiq (asfotase alfa), especially for people who are female, 0-1 old, have been taking the drug for 1 - 2 years also take Gabapentin, and have Hypophosphatasia.

The phase IV clinical study analyzes which people have Urinary tract infection when taking Strensiq. It is created by eHealthMe based on reports of 7,139 people who have side effects when taking Strensiq from the FDA, and is updated regularly.

What is Strensiq?

Strensiq has active ingredients of asfotase alfa. eHealthMe is studying from 7,141 Strensiq users. Check the latest studies of Strensiq.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,014 drugs and 3,957 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

7,139 people reported to have side effects when taking Strensiq.
Among them, 33 people (0.46%) have Urinary tract infection.

Could Strensiq cause Urinary tract infection?

Among these 33 people:

How long have people been on Strensiq when they have Urinary tract infection? *

What is the gender of people who have Urinary tract infection when taking Strensiq? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Urinary tract infection when taking Strensiq? *

What are other drugs people take besides Strensiq? *

What are other side effects people have besides Urinary tract infection? *

Injection Site Reaction: 5 people, 15.15%
Injection Site Pain: 4 people, 12.12%
Fatigue (feeling of tiredness): 4 people, 12.12%
Sinusitis (inflammation of sinus): 3 people, 9.09%
Joint Pain: 3 people, 9.09%
Nephritis (inflammation of the nephrons in the kidneys): 3 people, 9.09%
Nephrocalcinosis (a condition in which calcium levels in the kidneys are increased): 3 people, 9.09%
Nosocomial Infection (infection from hospital): 3 people, 9.09%
Pneumonia: 3 people, 9.09%
Fever: 3 people, 9.09%

What are the existing conditions these people have? *

Hypophosphatasia (metabolic bone disease): 22 people, 66.67%
Agitation (state of anxiety or nervous excitement): 3 people, 9.09%
Cellulitis (infection under the skin): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Strensiq and have Urinary tract infection?

- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Strensiq:

Strensiq (7,141 reports)

Browse all side effects of Strensiq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection:

Urinary tract infection (3,014 drugs)

Browse all the conditions that are associated with Urinary tract infection:

Urinary tract infection (3,957 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on asfotase alfa (the active ingredients of Strensiq) and Strensiq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.